Evolutionary Tree Capital Management, LLC Beam Therapeutics Inc. Transaction History

Evolutionary Tree Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$39.79 - $70.31 $509,630 - $900,530	-12,808 Reduced 40.16%	19,085 $909,000
Q2 2022 Aug 11, 2022	SELL	$29.86 - $62.36 $71,753 - $149,851	-2,403 Reduced 7.01%	31,893 $1.24 Million
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $743,462 - $1.14 Million	-13,837 Reduced 28.75%	34,296 $1.97 Million
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $254,598 - $370,781	3,743 Added 8.43%	48,133 $3.84 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $30,204 - $47,828	358 Added 0.81%	44,390 $3.86 Million
Q2 2021 Aug 12, 2021	BUY	$64.12 - $128.71 $324,831 - $652,044	5,066 Added 13.0%	44,032 $5.67 Million
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $752,217 - $1.27 Million	10,553 Added 37.14%	38,966 $3.12 Million
Q4 2020 Feb 10, 2021	BUY	$22.24 - $95.63 $631,905 - $2.72 Million	28,413 New	28,413 $2.32 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.